Update Venetoclax in CLL
Zanubrutinib
(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
UpToDate
Patient Power
NCCN COVID-19 Resources Page